Pennsylvania’s medical marijuana industry has made $350 million in sales since the state’s first dispensary opened in February 2018, nearly tripling in five months.

Anxiety disorders and Tourette syndrome have been approved by the state as conditions eligible for medical marijuana treatment starting on July 20.